Abstract
The aim is to review on medication related osteonecrosis of the jaw its definition, prevention, diagnosis and treatment. Skeletal complications due to osteoporosis or bone metastases are associated with considerable pain, increased mortality, and reduced quality of life. Agents that prevent bone resorption such as bisphosphonates or denosumab can reduce the risk of skeletal-related events and are widely used in patients with osteoporosis or bone metastases. However, MRONJ can be treated and the likelihood of developing this condition can be reduced through prophylactic dental care and the maintenance of good oral hygiene. This review describes the incidence and pathophysiology of MRONJ and provide guidance for dental practitioners on the screening, prophylactic treatment, diagnosis, and management of patients with this condition.
| Original language | English |
|---|---|
| Pages (from-to) | 2036-2040 |
| Number of pages | 5 |
| Journal | International Journal of Dentistry and Oral Science |
| Volume | 8 |
| Issue number | 3 |
| State | Published - Mar 2021 |
| Externally published | Yes |
Keywords
- Bisphosphonates
- Denosaumab
- Jaw
- Osteonecrosis
- Resorption
Fingerprint
Dive into the research topics of 'A review on medication-related osteonecrosis of the jaw: Definition and best practice for prevention, diagnosis, and treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver